GAST and gastric cancer: Therefore, additional studies are needed to develop a comprehensive score with the GCRS, H. pylori infection status, polygenic risk score, and other serum biomarkers (e.g., PG I, PG II, and gastrin-17) to further optimize the risk prediction of GC.